New Vaccine Developed With AI Will Be Tested on Humans in the United States

Monday, 08 July 2019 - 9:26AM
Artificial Intelligence
Monday, 08 July 2019 - 9:26AM
New Vaccine Developed With AI Will Be Tested on Humans in the United States
< >
Adapted from Pixabay Images
A "turbo-charged" flu vaccine developed using artificial intelligence (AI) is about to undergo human trials in the United States. According to Yahoo, the vaccine, developed by researchers at Flinders University in Australia, contains an immune system-stimulating component that will make the vaccine more effective against the flu. Lead researcher Nikolai Petrovsky said that this is the first time to his knowledge that a vaccine partially developed by AI had made it to human trials.


Using AI to parse and sort data gave the researchers an incredible advantage in terms of time, as they were able to narrow down promising compounds far more quickly than conventional methods would have allowed.


"Normally, big companies like GSK will screen millions of compounds," Petrovsky said, "with thousands of people working week in week out on this for about five years. It costs hundreds of millions of dollars to come up with one lead." AI allowed the Australian research team to develop the compound in just two years. "...Rather than screening millions of compounds we only worked with a handful," Petrovsky explained. "It took just a few weeks to synthesise them and then we tested them on human blood. The compounds then went through animal testing and are now in humans."


The study was funded by America's National Institute of Allergies and Infectious Diseases, which is currently seeking volunteers for testing.
Science
Medical Tech
Artificial Intelligence